IPO Trending
MAHALIFESME / BSEListed
Mahamaya Lifesciences

Incorporated in 2002, Mahamaya Lifesciences Limited is engaged in the manufacturing, registration, and export of high-quality crop protection products and bioproducts designed to enhance soil and crop health. The company specializes in pesticide formulations and supplies bulk products to leading Indian agrochemical players as well as multinational corporations (MNCs). Mahamaya imports global research-based molecules, registers them with the Central Insecticides Board, and markets both technical and value-added formulations. The company has invested significantly in global registrations and currently exports to markets such as the Dominican Republic, Egypt, Ethiopia, Jordan, UAE, and Turkey. Its portfolio spans bulk formulations, technical grade molecules, branded products, and export-focused formulations.

₹108 - ₹1141.71x sub
Listed Price₹116.00
Listing Gain+1.75%

Subscription Status

1.71xTotal Demand
Updated 20 Oct 2026, 01:30 AM
QIB1.19x
Fully Subscribed (Safe)Offered: 11,76,000 sh
Nib3.99x
Popular / Warm DemandOffered: 8,82,000 sh
Hnis(10l +)5.53x
Popular / Warm DemandOffered: 5,88,000 sh
Hnis (2-10l)0.90x
Steady / DevelopingOffered: 2,94,000 sh
Retail1.02x
Fully Subscribed (Safe)Offered: 20,59,200 sh
CategoryOfferedAppliedTimes
QIB11,76,00014,01,6001.19x
Nib8,82,00035,14,8003.99x
Hnis(10l +)5,88,00032,50,8005.53x
Hnis (2-10l)2,94,0002,64,0000.9x
Retail20,59,20021,07,2001.02x

Segment Subscription Demand

Segment / CategoryDemand (Shares)Offered (Shares)Times Sub.
QIB15.9813.411.19x
Fiis6.660Open
Others9.320Open
Retail24.0223.471.02x
Hnis 2+3.013.350.90x
Hnis 10+37.066.75.53x

Application-wise Breakup

CategoryReservedAppliedTimes Sub.
QIB09Open
Nib0146Open
Retail8588781.02x
Hnis(10l +)163830.51x
Hnis (2-10l)82630.77x
Bidding status cross-verified with live IPO subscription numbers ↗BSE & NSE Bidding Portal Feed

About Mahamaya Lifesciences IPO Subscription Demand

Live subscription status and bidding analysis for Mahamaya Lifesciences (MAHALIFE) IPO. The issue is subscribed 1.71x overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII/HNI), and Retail Individual Investors (RII). Check real-time grey market demand on our GMP Tracker or review full issue details, lot size, and price band on the IPO Details Page.

Frequently Asked Questions